- Analyzers
- Rapid Testing Devices
- Consumables
This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Urine drug testing is routinely utilised in clinical, employment, educational, and legal contexts, and incorrect results interpretation can have serious negative effects on the person being tested. Clinicians face difficulties when trying to correctly interpret urine drug test results because of improvements in drug testing technology as well as an increase in the number of novel chemicals that are abused. Because urine testing is rapid, noninvasive, and capable of detecting a wide range of substances, it is the most popular. Depending on the medication used, it may be able to detect medicines that were used within the last 1 to 4 days, or even longer. Recent scientific advancements in the equipment and materials used to test urine samples for drugs of abuse have made these tests, when properly executed, highly accurate for cannabis and cocaine, the two most common drugs of abuse.
The drug of abuse testing market is projected to expand at a CAGR of 5.6% during the forecast period.
Siemens Healthineers, Thermo Fisher Scientific Inc., Drägerwerk AG & Co., Hoffmann-La Roche Ltd., Danaher Corporation
North America is the fastest-growing region for drug of abuse testing market